Agoglia Hoeltzel Mary T
Known title: SVP Tax & Chief Acct. OfficerCIK: 0001467807
Associated companies
Transaction History
| CI | ▲ Buy | Option Exercise | 5,946 | $719K | 5/14/2024 | View on chart |
| CI | ▼ Sell | Open Market | 5,946 | $2.1M | 5/14/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 224 | $75K | 3/1/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 532 | $177K | 3/1/2024 | View on chart |
| CI | ▲ Buy | Grant | 1,240 | $0 | 3/1/2024 | View on chart |
| CI | ▲ Buy | Option Exercise | 4,867 | $380K | 2/7/2024 | View on chart |
| CI | ▼ Sell | Open Market | 4,867 | $1.6M | 2/7/2024 | View on chart |
| CI | ▲ Buy | Option Exercise | 4,500 | $351K | 8/8/2023 | View on chart |
| CI | ▼ Sell | Open Market | 12,250 | $3.6M | 8/8/2023 | View on chart |
| CI | ▼ Sell | Other | 504 | $128K | 5/22/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 106 | $31K | 3/1/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 72 | $21K | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 376 | $111K | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 1,341 | $0 | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 425 | $0 | 2/22/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 7,044 | $414K | 8/9/2022 | View on chart |
| CI | ▼ Sell | Open Market | 7,044 | $2.0M | 8/9/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 61 | $14K | 3/1/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 154 | $35K | 2/25/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 215 | $49K | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 695 | $0 | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 551 | $0 | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.